Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03396172

FreeDom: Innovative Strategy for the Management of COPD Exacerbations

FreeDom : Innovative Strategy for the Management of COPD Exacerbations Combining Early Hospitalisation Discharge, Automated Oxygen Weaning at Home, Telemedicine and Tele-rehabilitation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation. The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.

Detailed description

The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy will enable an early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation. The main hypothesis of this study is that a strategy for an early return home with a home hospitalization managed by telemedicine will reduce the length of hospitalization by 50 percent from 30 days.

Conditions

Interventions

TypeNameDescription
OTHERControlThe hospitalization will take place in the usual setting and the hospital discharge will be decided by pulmonologists according to the usual criteria
DEVICEFreeDomEarly return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation

Timeline

Start date
2018-05-24
Primary completion
2025-06-01
Completion
2025-12-01
First posted
2018-01-10
Last updated
2024-06-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03396172. Inclusion in this directory is not an endorsement.